Acticor Biotech (XPAR:ALACT) FCF Margin % : 0.00% (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Acticor Biotech FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Acticor Biotech's Free Cash Flow for the six months ended in Jun. 2023 was €-7.97 Mil. Acticor Biotech's Revenue for the six months ended in Jun. 2023 was €0.00 Mil. Therefore, Acticor Biotech's FCF Margin % for the quarter that ended in Jun. 2023 was 0.00%.

As of today, Acticor Biotech's current FCF Yield % is -83.40%.

The historical rank and industry rank for Acticor Biotech's FCF Margin % or its related term are showing as below:

During the past 6 years, the highest FCF Margin % of Acticor Biotech was -11066.00%. The lowest was -11066.00%. And the median was -11066.00%.

XPAR:ALACT's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -139.31
* Ranked among companies with meaningful FCF Margin % only.

Acticor Biotech FCF Margin % Historical Data

The historical data trend for Acticor Biotech's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acticor Biotech FCF Margin % Chart

Acticor Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

FCF Margin %

Get a 7-Day Free Trial

-11,066.00

Acticor Biotech Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
FCF Margin %	Get a 7-Day Free Trial				-	-	-	-	-

Competitive Comparison of Acticor Biotech's FCF Margin %

For the Biotechnology subindustry, Acticor Biotech's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Acticor Biotech's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Acticor Biotech's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Acticor Biotech's FCF Margin % falls into.

Acticor Biotech FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Acticor Biotech's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	-12.11	/	0
	=	%

Acticor Biotech's FCF Margin for the quarter that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2023 )	/	Revenue (Q: Jun. 2023 )
	=	-7.966	/	0
	=	%

Acticor Biotech FCF Margin % Related Terms

Thank you for viewing the detailed overview of Acticor Biotech's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Acticor Biotech (XPAR:ALACT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acticor Biotech SA (XPAR:ALACT) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

7V7:Germany

Address

82 Avenue du Maine, Wojo Building, Paris, FRA, 75014

Website

https://www.acticor-biotech.com

Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke.

Acticor Biotech (XPAR:ALACT) Headlines

No Headlines